Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT02067793. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Randomized, Double-Blind, Multiple-Dose Level, Placebo Controlled, Single Intravenous Dose, Parallel Efficacy and Safety Study of NRX-1074 in Subjects With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of NRX-1074 following a single intravenous dose in subjects with major depressive disorder.
Study identification
- NCT ID
- NCT02067793
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2014
- Primary completion
- Jan 31, 2015
- Completion
- Jan 31, 2015
- Last update posted
- Mar 16, 2016
2014 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Research Partners | Oakland | California | 94612 | — |
| Psychiatric Medicine Associates | Skokie | Illinois | 60076 | — |
| University of Kansas School of Medicine Clinical Trial Unit | Wichita | Kansas | 67214 | — |
| Boston Clinical Trials, Inc. | Roslindale | Massachusetts | 02131 | — |
| Psychiatric Care and Research Center | O'Fallon | Missouri | 63368 | — |
| Mount Sinai School of Medicine | Elmsford | New York | 10523 | — |
| New York State Psychiatric Institute | New York | New York | 10032 | — |
| Lindner Center of HOPE | Mason | Ohio | 45040 | — |
| Research Strategies Memphis | Memphis | Tennessee | 38119 | — |
| Research Across America | Dallas | Texas | 75234 | — |
| Lifetree Clinical Research | Salt Lake City | Utah | 84106 | — |
| Psychiatric Alliance of the Blue Ridge | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02067793, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02067793 live on ClinicalTrials.gov.